Lodrane D (brompheniramine recalls

The FDA has published 1 recall involving Lodrane D (brompheniramine since 2016. The latest was reported on 22 Jun 2016. Most were for labeling errors. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 22 Jun 2016

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 1 100%

Why lodrane d (brompheniramine is recalled

Labeling Errors1100%

Companies

Valeant Pharmaceuticals North America1100%

By year

20161100%

All lodrane d (brompheniramine recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
22 Jun 2016Drug	CLASS III	Lodrane D (Brompheniramine maleate 4 mg recalled	Valeant Pharmaceuticals North America	Labeling Errors	Nationwide

Should you stop taking Lodrane D (brompheniramine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.